MedPath

Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation

Completed
Conditions
Arterial Hypertension
Resistant Arterial Hypertension
Registration Number
NCT03243045
Lead Sponsor
National Institute of Cardiology, Laranjeiras, Brazil
Brief Summary

It has been proposed that the modulation of the activity of the sympathetic nervous system, through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vascular reactivity and consequent improvement of macro and microcirculation.

The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients presenting with resistant arterial hypertension.

Detailed Description

Arterial hypertension is still a serious public health problem with considerable social and economic impact. Arterial hypertension is the result from a complex interaction between environmental and genetic factors that initiate and perpetuate elevated blood pressure. Studies show that about 10% of patients undergoing treatment have resistant hypertension, defined as high blood pressure refractory to at least three antihypertensive drugs. It is known that the sympathetic nervous system plays a fundamental role in the pathophysiology of hypertension, contributing to metabolic and vascular changes. The sympathetic nervous system has also a major role in the pathophysiology of arterial hypertension. Arterial hypertension has also been associated with functional microcirculatory alterations as well as systemic microvascular endothelial dysfunction in hypertensive patients, confirmed by different microcirculatory flowmetry techniques. In this context, it has been proposed that the modulation of the sympathetic nervous system through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vascular reactivity and consequent improvement of macro and microcirculation.

The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients with resistant hypertension.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Resistant arterial hypertension under pharmacological treatment
Exclusion Criteria
  • secondary arterial hypertension
  • renal dysfunction
  • severe kidney disease
  • congestive heart failure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cutaneous microvascular reactivityBefore and one, three, six and twelve months after intervention

Evaluation of microvascular reactivity using laser speckle contrast imaging

Cutaneous microvascular flowBefore and one, three, six and twelve months after intervention

Evaluation of the microvascular flow using laser speckle contrast imaging

Secondary Outcome Measures
NameTimeMethod
Cutaneous capillary densityBefore and one, three, six and twelve months after intervention

Evaluation of cutaneous capillary density and reactivity using video-capillaroscopy

Trial Locations

Locations (1)

National Institute of Cardiology

🇧🇷

Rio de Janeiro, Brazil

© Copyright 2025. All Rights Reserved by MedPath